Lorimer; Stephen D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lorimer; Stephen D..The latest application filed is for "compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease".

Company Profile

0.3.5

Lorimer; Stephen D. - Dundein NZ
Lorimer; Stephen D. - Dunedin NZ
Lorimer; Stephen D. - Opoho NZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease Grant 7,763,747 - Snow , et al. July 27, 2	2010-07-27
Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis Grant 7,601,876 - Snow , et al. October 13, 2	2009-10-13
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease App 20090197965 - Snow; Alan D. ; et al.	2009-08-06
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease Grant 7,514,583 - Snow , et al. April 7, 2	2009-04-07
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease App 20090069432 - Snow; Alan D. ; et al.	2009-03-12
Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis App 20070225362 - Snow; Alan D. ; et al.	2007-09-27
Isolation, purification and synthesis of procyanidin B2 and uses thereof App 20040260076 - Castillo, Gerardo M. ; et al.	2004-12-23
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and parkinson's disease App 20040127555 - Snow, Alan D. ; et al.	2004-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.